跳到正文

ROTE WILLIAM E. 内部人交易:近期 SEC Form 4 交易

过去 18 个月,ROTE WILLIAM E.(CIK 1698262)在 1 家公司共报告 21 笔 SEC Form 4 内部人交易(最近一笔 2026-09-17)。

日期公司身份类型股数市值
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入39,650$712,114
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出63,907$4.0M
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出29,021$1.8M
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出3,000$190,952
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出270$17,634
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入350$6,286
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入55,000$850,300
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入57,500$1.5M
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出65,104$4.1M
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出47,746$3.0M
2026-09-17Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入39,000$984,750
2026-05-06Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入4,250$0
2026-05-06Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出2,763$121,434
2026-04-23Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出9,100$355,719
2026-04-15Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入14,000$0
2026-02-03Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入20,090$0
2026-02-03Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出12,446$409,100
2025-12-29Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入60,000$1.2M
2025-12-29Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出60,000$2.4M
2025-05-05Travere Therapeutics, Inc. (TVTX)Chief Research Officer买入4,920$0
2025-05-05Travere Therapeutics, Inc. (TVTX)Chief Research Officer卖出3,198$67,318

来源:SEC Form 4 申报文件 · 截至 2026-09-17